Global Non-Hematological Cancers Market Is Expected to Reach $141 Billion by 2021; Finds New Report
The global treatment market for non-hematological cancers, which includes breast, colorectal, lung and prostate cancers, among others, will almost double from $72.9 billion in 2014 to $140.8 billion in 2021, at a compound annual growth rate (CAGR) of 9.9%, according to new research report.
View full press release